AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Systemic Sclerosis (SSc)

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site๐Ÿ“ Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases NCT06980597Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: OL-108 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs) NCT07650565NA1 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Blood Sample Collection A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases NCT07284797Phase 11 site๐Ÿ“ Melbourne Xencor, Inc. ยท Tests: XmAb657 Platform Clinical Study for Conquering Scleroderma NCT06195072Phase 234 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Scleroderma Research Foundation, Inc. ยท Tests: Amlitelimab, BI 1015550 (Nerandomilast), Placebo Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis NCT06256575NA5 sites๐Ÿ“ Calgary๐Ÿ“ Halifax๐Ÿ“ London Primus Pharmaceuticals ยท Tests: Diosmin, Placebo Safety Study of CC312 in Autoimmune Disease Patients NCT06888960EARLY Phase 11 site๐Ÿ“ Tianjin CytoCares Inc ยท Tests: CC312 Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders NCT06434363Phase 1, Phase 22 sites๐Ÿ“ Houston๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Tafasitamab, Fludarabine phosphate, Cyclophosphamide, Tafasitamab and NK cells A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease NCT07085104Phase 117 sites๐Ÿ“ Phoenix๐Ÿ“ Loma Linda๐Ÿ“ Aurora Allogene Therapeutics ยท Tests: ALLO-329, Cyclophosphamide, Fludarabine A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07104721Phase 11 site๐Ÿ“ Hefei China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases NCT07301164EARLY Phase 11 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: BCT301 FT839 in Autoimmune Diseases NCT07800871Phase 1, Phase 21 site๐Ÿ“ Fullerton Fate Therapeutics ยท Tests: FT839 Systemic Sclerosis DIet for GastrointESTinal Symptoms NCT07402226NA1 site๐Ÿ“ Ann Arbor University of Michigan ยท Tests: Diet 1: Restriction of fermentable carbohydrates, Diet 2: Elimination of foods harmful to gut barrier and microbiome, Dโ€ฆ A Study of ATG-201 in Adult Participants With Autoimmune Diseases NCT07732309Phase 122 sites๐Ÿ“ Bengbu๐Ÿ“ Hefei๐Ÿ“ Beijing Antengene Biologics Limited ยท Tests: ATG-201 The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life NCT06675344NA4 sites๐Ÿ“ New Orleans๐Ÿ“ Ann Arbor๐Ÿ“ Pittsburgh Robyn T. Domsic, MD, MPH ยท Tests: Apollo Neuro Device, Sham device A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases NCT07413341Phase 11 site๐Ÿ“ Shanghai Therorna ยท Tests: TI-0032-III injection Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site๐Ÿ“ Jerusalem Polina Stepensky ยท Tests: HBI0101 CART Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images NCT07228429n/a1 site๐Ÿ“ New Haven Yale University ยท Tests: Sodium Thiosulfate (STS), Sodium Thiosulfate Injection Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases NCT06614270NA1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Anti-CD19 IL-10/IL15 CAR-NK A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease NCT05878717Phase 2, Phase 3134 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Scottsdale GlaxoSmithKline ยท Tests: Belimumab, Placebo Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis NCT03630211Phase 23 sites๐Ÿ“ Pittsburgh๐Ÿ“ Pittsburgh๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: Cyclophosphamide, Mesna, Rituximab, Alemtuzumab, Thiotepa Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis NCT07236970n/a5 sites๐Ÿ“ Granada๐Ÿ“ Santander๐Ÿ“ Barcelona Alejandro Cruz Utrilla Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis NCT06865118n/a1 site๐Ÿ“ Oslo Oslo University Hospital CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH NCT06947460Phase 1, Phase 21 site๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: CD19-BCMA CAR-T cells infusion Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD NCT07491523n/a1 site๐Ÿ“ Pรกtrai University of Patras ยท Tests: Antifibrotic drugs (nidanib or pirfenidone), MMF Immunosuppression The Effect of Progressive Muscle Relaxation Exercises on Fatigue, Dyspnea, and Respiratory Function in Patients With Systemic Sclerosis NCT07842133NA1 site๐Ÿ“ Gaziantep University of Gaziantep ยท Tests: Progressive Muscle Relaxation Exercise Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy NCT07150000n/a1 site๐Ÿ“ Bonn University of Bonn ยท Tests: Ex Vivo Assay Efficacy and Safety of HN2301 in Autoimmune Diseases๏ผˆAIDs๏ผ‰ NCT06801119Phase 11 site๐Ÿ“ Hefei Shenzhen MagicRNA Biotechnology Co., Ltd ยท Tests: HN2301 injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy